Piper Jaffray analyst comments on Vaping On October 8, Piper Jaffray senior analyst Michael Lavery voiced his opinions about the impact of vaping on cannabis stocks in an interview on The Exchange on CNBC. He explained that vaping concerns may ironically prove beneficial to regulated cannabis players in the long term. This, however, would require regulatory authorities to definitively prove a link between black market products and illnesses.
On September 14, a Reuters report identified two illicit marijuana vape products, Chronic Carts and Dank Vapes, as the possible culprits causing vaping-related lung illnesses. However, this evidence is scant, and more proof will be required to clear the names of regulated cannabis products from the vaping-related allegations.
The October 8 episode of The Exchange also highlighted the difficulty cannabis companies may face in raising capital due to the ongoing vaping crisis. Hence, investors are advised to be on the lookout for companies with stronger balance sheets.
https://marketrealist.com/2019/10/vaping-cannabis-stocks-piper-jaffray-weighs-in/?utm_source=yahoo&utm_medium=feed&yptr=yahoo